212 related articles for article (PubMed ID: 23384536)
1. Serum free light chain reference values: a critical approach.
Altinier S; Seguso M; Zaninotto M; Varagnolo M; Adami F; Angeli P; Plebani M
Clin Biochem; 2013 May; 46(7-8):691-3. PubMed ID: 23384536
[TBL] [Abstract][Full Text] [Related]
2. Effects of Long-Term Storage on Serum Free Light Chain Stability.
Hörber S; Klein R; Peter A
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
[TBL] [Abstract][Full Text] [Related]
3. Clinical and preclinical validation of the serum free light chain assay: identification of the critical difference for optimized clinical use.
Hansen CT; Münster AM; Nielsen L; Pedersen P; Abildgaard N
Eur J Haematol; 2012 Dec; 89(6):458-68. PubMed ID: 22998393
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the N-latex serum free light chain assay on the Siemens BNII analyzer and agreement with The Binding Site FreeLite assay on the SPA
White-Al Habeeb NMA; Earle T; Spencer M; Blasutig IM
Clin Biochem; 2018 Jan; 51():90-96. PubMed ID: 28512013
[TBL] [Abstract][Full Text] [Related]
5. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population.
Abadie JM; Bankson DD
Ann Clin Lab Sci; 2006; 36(2):157-62. PubMed ID: 16682511
[TBL] [Abstract][Full Text] [Related]
6. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
7. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool.
Campbell JP; Heaney JL; Shemar M; Baldwin D; Griffin AE; Oldridge E; Goodall M; Afzal Z; Plant T; Cobbold M; Jefferis R; Jacobs JF; Hand C; Drayson MT
Clin Chem Lab Med; 2017 Mar; 55(3):424-434. PubMed ID: 27505089
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods.
Jacobs JFM; de Kat Angelino CM; Brouwers HMLM; Croockewit SA; Joosten I; van der Molen RG
Clin Chem Lab Med; 2018 Jan; 56(2):312-322. PubMed ID: 28771430
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
10. A multicentre study comparing two methods for serum free light chain analysis.
Lock RJ; Saleem R; Roberts EG; Wallage MJ; Pesce TJ; Rowbottom A; Cooper SJ; McEvoy ED; Taylor JL; Basu S
Ann Clin Biochem; 2013 May; 50(Pt 3):255-61. PubMed ID: 23605135
[TBL] [Abstract][Full Text] [Related]
11. Quantification of serum free light chain kappa and lambda by the SPAPLUS analyser.
Maisin D; Lepoutre T; Gruson D; Wallemacq P
Clin Biochem; 2013 May; 46(7-8):622-6. PubMed ID: 23291296
[TBL] [Abstract][Full Text] [Related]
12. Performance Evaluation of Serum Free Light Chain Analysis: Nephelometry vs Turbidimetry, Monoclonal vs Polyclonal Reagents.
Messiaen AS; De Sloovere MMW; Claus PE; Vercammen M; Van Hoovels L; Heylen O; Debrabandere J; Vanpoucke H; De Smet D
Am J Clin Pathol; 2017 Jun; 147(6):611-622. PubMed ID: 28575180
[TBL] [Abstract][Full Text] [Related]
13. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
Wolff F; Thiry C; Willems D
Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
[TBL] [Abstract][Full Text] [Related]
15. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.
Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H
Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of determination of free light chains (Kappa and Lambda) in plasma and serum by Swedish laboratories as monitored by external quality assessment.
Rollborn N; Jakobsson J; Campbell A; Nordin G; Karlsson M; Larsson A; Kultima K
Clin Biochem; 2023 Jan; 111():47-53. PubMed ID: 36241061
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
[TBL] [Abstract][Full Text] [Related]
19. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study.
Cotten SW; Shajani-Yi Z; Cervinski MA; Voorhees T; Tuchman SA; Korpi-Steiner N
Clin Biochem; 2018 Aug; 58():100-107. PubMed ID: 29885308
[TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of serum free light chain reference intervals in an ethnic Chinese population.
Liang YF; Chen WM; Wang QT; Zhai YH; Yang YJ; Liu JY; Levoguer A; Sun WH
Clin Lab; 2014; 60(2):193-8. PubMed ID: 24660530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]